Turku Bioscience Centre

Contact Details

Persons

  

  

  

1 of 10

  

  

  

---

• Aakula, Anna
• Abdelkader, Hend
• Abe, Oluwatosin
• Adel, Ketlin
• Akram, Sadia
• Alamaunu, Anneli
• Alanko, Jonna
• Andrabi, Syed
• Arsiola, Tiina
• Atefi, Atefeh
• Balint, Balazs
• Batkulwar, Kedar
• Bhardiya, Shruti Nitin
• Biradar, Rahul
• Bojovic, Itana
• Booth, Nicholas
• Buchacher, Tanja
• Chastney, Megan
• Coffey, Eleanor
• Courtney, Michael

Publications

  

  

  

144 of 175

  

  

  

---

• Serum Proteomes Distinguish Children Developing Type 1 Diabetes in a Cohort With HLA-Conferred Susceptibility  (2015)
• Serum Proteomic Profiling to Identify Biomarkers of Premature Carotid Atherosclerosis  (2018)
• Serum proteomics of mother-infant dyads carrying HLA-conferred type 1 diabetes risk  (2024)
• Serum proteomics to detect early changes in type 1 diabetes and carotid atherosclerosis  (2018)
• Sex-Dependent Improvement in Survival of Parkinson's Disease Patients  (2020)
• SHANK3 conformation regulates direct actin binding and crosstalk with Rap1 signaling  (2021)
• SHANK3 depletion leads to ERK signalling overdose and cell death in KRAS-mutant cancers  (2024)
• SHANK proteins limit integrin activation by directly interacting with Rap1 and R-Ras  (2017)
• SHARPIN is an endogenous inhibitor of beta 1-integrin activation  (2011)
• SHARPIN modulates ligand-specific mechanosensing through regulation of integrin binding dynamics  (2016)